Prevention

ACIP: New Recommendations for Herpes Zoster Vaccine Administration

ACIP: New Recommendations for Herpes Zoster Vaccine Administration

By

The Advisory Committee on Immunization Practices has provided 3 new recommendations to supplement its original 2008 report, as well as a cost-effectiveness analysis from the CDC.

Higher Influenza Vaccination Uptake Associated With Provider Recommendations

Higher Influenza Vaccination Uptake Associated With Provider Recommendations

By

A new study indicates that early-season influenza vaccination coverage was significantly higher among adults aged ≥18 years with a provider visit and recommendation/offer for vaccination.

Meningococcal Serogroup B Vaccine Safe, Effective Short-Term in Children, Adolescents

Meningococcal Serogroup B Vaccine Safe, Effective Short-Term in Children, Adolescents

By

In the overall comparative meta-analyses, the multicomponent meningococcal serogroup B vaccine had increased immunogenicity (short-term and persistent) compared with recombinant meningococcal serogroup B vaccine against strain NZ98/254.

ACIP: 2018 Immunization Schedule for Children, Adolescents Released

ACIP: 2018 Immunization Schedule for Children, Adolescents Released

By

The ACIP has released the 2018 Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger.

ACIP: 2018 Adult Immunization Schedule Now Available

ACIP: 2018 Adult Immunization Schedule Now Available

By

The ACIP has released the 2018 Recommended Immunization Schedule for Adults Aged 19 Years or Older.

Patient Reminders, Recall Systems Increase Immunization Rates

Patient Reminders, Recall Systems Increase Immunization Rates

Patient reminder and recall systems seem to be effective for improving receipt of immunizations.

Repeat Influenza Vaccination Effective in Preventing Severe Influenza in Elderly

Repeat Influenza Vaccination Effective in Preventing Severe Influenza in Elderly

By

Prevention of severe and fatal infection caused by influenza was observed mainly in patients who were vaccinated in both the current and previous seasons, reinforcing the recommendation of annual vaccination in older adults.

ACIP Recommends Third Dose of MMR Vaccine for People With Increased Risk

ACIP Recommends Third Dose of MMR Vaccine for People With Increased Risk

By

Individuals who have previously received 2 doses of a mumps-containing vaccine should receive a third dose if at increased risk for developing mumps.

ACIP Issues Updated Recommendations for Preventing HBV Infection

ACIP Issues Updated Recommendations for Preventing HBV Infection

By

The Advisory Committee on Immunization Practices has issued updated recommendations for HBV prevention.

Influenza Vaccine in Children: Recommendations From the AAP

Influenza Vaccine in Children: Recommendations From the AAP

By

Providers may continue to offer vaccines until June 30 of every year, the date marking the end of the influenza season, because influenza is unpredictable.

Cost-Effectiveness of New Adjuvanted Herpes Zoster Subunit Vaccine

Cost-Effectiveness of New Adjuvanted Herpes Zoster Subunit Vaccine

By

At a price of $280 per series, the adjuvanted herpes zoster subunit vaccine would cost less than the live attenuated herpes zoster vaccine and has a high probability of offering good value.

SHEA Releases Contact Precaution Guidelines for Multidrug-Resistant Infections

SHEA Releases Contact Precaution Guidelines for Multidrug-Resistant Infections

By

A new expert guidance concerning contact precautions for multidrug resistant bacteria has been released.

Strategies for Preventing Group B Streptococcus in Infants

Strategies for Preventing Group B Streptococcus in Infants

By

Expert from the National Center for Immunization and Respiratory Diseases, a division of the CDC, discusses prevention strategies for group B streptococcus in infants, including the development of a maternal vaccine.

State-Mandated Counseling Lowers Vaccine Exemption Rates

State-Mandated Counseling Lowers Vaccine Exemption Rates

Mandated counseling to obtain a vaccine exemption was associated with a decrease in exemption rates and an increase in vaccine coverage.

Herpes zoster subunit vaccine may be more cost-effective than live attenuated zoster vaccine

The new adjuvanted herpes zoster subunit vaccine was more efficacious and less expensive for all ages at the price of $280 per series as compared to the single-dose herpes zoster vaccine.

Universal Influenza Vaccine: A Game Changer in Prevention

Universal Influenza Vaccine: A Game Changer in Prevention

By

A dedicated research effort led by NIH's National Institute of Allergy and Infectious Diseases is aimed at developing a universal influenza vaccine that would confer better and longer-lasting protection against influenza virus strains.

Primary Care: Next Frontier in Managing HIV Care

Primary Care: Next Frontier in Managing HIV Care

Primary care providers will play an important role in preventing the next wave of HIV infections.

Probiotics Effective for Preventing <i>C difficile</i>-Associated Diarrhea

Probiotics Effective for Preventing C difficile-Associated Diarrhea

By

Short-term use of probiotics appears to be safe and effective when used along with antibiotics in patients who are not immunocompromised or severely debilitated.

Safety, Efficacy of 2 Zika Virus Vaccine Trials Reported

Safety, Efficacy of 2 Zika Virus Vaccine Trials Reported

By

Two trials assessing different vaccination schedules and delivery methods for Zika virus vaccine reveal the vaccines to be safe, well tolerated, and immunogenic.

Can We Prevent HIV and STIs Through School Programs?

Can We Prevent HIV and STIs Through School Programs?

By

Although a positive impact on behavior change has been reported following the implementation of curriculum-based programs, there is a lack of clear evidence that school-based educational interventions directly prevent HIV/STIs.

Trends in Meningococcal Disease Following MenACWY Vaccine Introduction

Trends in Meningococcal Disease Following MenACWY Vaccine Introduction

By

Incidence of meningococcal disease in the United States has decreased across all age groups.

Improving Campaigns Regarding the Value of Adult Vaccines

Improving Campaigns Regarding the Value of Adult Vaccines

By

Educational campaigns regarding the value of vaccines should go beyond facts and statistics to integrating social psychological considerations with health communication principles.

Antibiotics, Mechanical Bowel Preparation Associated With Reduced SSIs

Antibiotics, Mechanical Bowel Preparation Associated With Reduced SSIs

By

Oral antibiotics combined with mechanical bowel preparation should be considered for all patients undergoing left-sided colorectal cancer resections.

Linkage to HIV Care: To Give or Not to Give Financial Incentives?

Linkage to HIV Care: To Give or Not to Give Financial Incentives?

By

Use of incentives makes the most sense with disadvantaged populations including homeless, drug users, and people in developing countries.

Inappropriate Antibiotic Use for Acute Bronchitis Highest in Younger Adults

Inappropriate Antibiotic Use for Acute Bronchitis Highest in Younger Adults

By

The adult population is a key target of antibiotic stewardship efforts for acute bronchitis, since over half of unnecessary prescribing for bronchitis occurs in adult patients.

Preventing HCV Transmission: Utility of Needle/Syringe Programs

Preventing HCV Transmission: Utility of Needle/Syringe Programs

By

Needle/syringe programs (NSPs) have proven to be effective and moderately effective in preventing transmission of HCV infection and minimizing drug-related harms among people who inject drugs in Europe and North America, respectively.

Primary HPV Testing Recommendation Among US Physicians

Primary HPV Testing Recommendation Among US Physicians

By

Many US physicians recommended primary HPV testing for women of all ages, contrary to guidelines which limit this screening approach to women ≥25 years old.

CDC Updates Guidelines for Seasonal Influenza Vaccines

CDC Updates Guidelines for Seasonal Influenza Vaccines

By

For the 2017-18 season, quadrivalent and trivalent influenza vaccines will be available; live attenuated influenza vaccine is not recommended for use.

FDA Approves Letermovir for Treatment and Prevention of CMV

FDA Approves Letermovir for Treatment and Prevention of CMV

By

The FDA has approved letermovir for the treatment and prevention of cytomegalovirus.

Curbing Parental Vaccine Hesitancy With Web-Based, Social Media Intervention

Curbing Parental Vaccine Hesitancy With Web-Based, Social Media Intervention

Providing pregnant women with web-based vaccine information with social media applications during pregnancy is linked to greater proportion of infants up-to-date with vaccination.

Sign Up for Free e-newsletters